Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Pharmaceutical Supply – Sodium Nitroprusside (50 mg/2 mL vial)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks the supply of one unit of Sodium Nitroprusside, USP, in a 2 mL vial containing 50 mg of sodium nitroprusside dihydrate, fully compliant with federal and military pharmaceutical standards. The product must meet the stringent quality and safety requirements mandated for use within the Department of Defense medical supply chain, ensuring it is suitable for deployment in clinical and field environments. The item is to be delivered to a military address in APO with ZIP code 96543-4010, indicating its intended use by U.S. military medical personnel in overseas or expeditionary operations. This is a subcontract under NAICS code 325412, which classifies it within pharmaceutical and medicine manufacturing, and was posted on July 19, 2026, with a response deadline of July 27, 2026. All submissions must align with the Department of Defense’s procurement protocols and be submitted via the DIBBS platform at the provided link. The contract does not specify any set-aside preferences and does not list a point of contact, suggesting that the procurement process is standardized and handled through established military supply channels without additional negotiation. Compliance with all regulatory requirements and timely delivery are critical to fulfilling the terms of this agreement.

General Info

One 2 mL vial of 50 mg sodium nitroprusside USP for DoD medical use, delivered to APO ZIP 96543-4010.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

APO, AP, 96543-4010, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of 1 unit of Sodium Nitroprusside, USP, 2 mL vial containing 50 mg sodium nitroprusside dihydrate, compliant with federal and military pharmaceutical standards.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
Medical Chemical Formulation and ManufacturingThe contract involves the manufacture of a modified 0.125 percent sodium hypochlorite solution, known as Dakins Solution Quarter Strength, packaged in 480 mL bottles. The scope includes full formulation development, rigorous quality control protocols, batch-by-batch testing to ensure consistency and safety, and strict compliance with medical-grade standards to meet regulatory requirements for clinical use. All production activities must adhere to guidelines ensuring sterility, stability, and purity, as the final product is intended for medical applications requiring precise chemical concentrations and contamination-free packaging. The contract is classified as a subcontract under NAICS code 325412 for pharmaceutical and medicine manufacturing, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. It was posted on July 20, 2026, with a response deadline of July 27, 2026, and the performance location is not specified, implying flexibility in manufacturing site selection as long as compliance and delivery standards are met. The solicitation is accessible through the DIBBS platform, and while no set-aside provisions or point of contact information is provided, bidders are expected to demonstrate proven capability in producing pharmaceutical-grade chemical solutions with validated quality systems and documented adherence to medical manufacturing regulations.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency